Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Apellis Pharmaceuticals, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $100 Billion
- Q4 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 97 shares of APLS stock, worth $2,342. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97
Previous 97
-0.0%
Holding current value
$2,342
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$295 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$287 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$285 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$243 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$232 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.65B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...